Document is current
Any future updates will be listed below
-
Authors
Gurtan, Allan M. https://orcid.org/0000-0003-1701-7821
Khalid, Shareef
Koch, Christopher https://orcid.org/0009-0006-1293-2333
Khan, Maleeha Zaman
Lamarche, Lindsey B. https://orcid.org/0000-0002-7200-3150
Splawski, Igor
Dolan, Elizabeth
Carrion, Ana M.
Zessis, Richard
Clement, Matthew E. https://orcid.org/0009-0004-1805-1452
Chen, Zhiping
Lindsley, Loren D.
Chiu, Yu-Hsin
Streeper, Ryan S. https://orcid.org/0009-0007-3429-988X
Denning, Daniel P.
Goldfine, Allison B.
Doyon, Brian
Abbasi, Ali
Harrow, Jennifer L. https://orcid.org/0000-0003-0338-3070
Tsunoyama, Kazuhisa
Asaumi, Makoto
Kou, Ikuyo https://orcid.org/0009-0005-2442-9965
Shuldiner, Alan R. https://orcid.org/0000-0001-9921-4305
Rodriguez-Flores, Juan L. https://orcid.org/0000-0002-0394-8062
Rasheed, Asif
Jahanzaib, Muhammad https://orcid.org/0000-0002-5101-8564
Mian, Muhammad Rehan
Liaqat, Muhammad Bilal
Raza, Syed Shahzaib
Sultana, Riffat
Jalal, Anjum https://orcid.org/0000-0002-9448-811X
Saeed, Muhammad Hamid
Abbas, Shahid
Memon, Fazal Rehman
Ishaq, Mohammad
Dominy, John E. https://orcid.org/0000-0001-7137-0672
Saleheen, Danish https://orcid.org/0000-0001-6193-020X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 29 March 2024
Accepted: 28 August 2024
First Online: 26 September 2024
Competing interests
: D.S. has received funding from Regeneron Pharmaceuticals, Eli Lilly & Company, Novartis, Merck, Astra Zeneca, NGM Biopharmaceuticals Inc., GSK, Astellas Pharma Inc. and Novo Nordisk. A.M.G., C.K., L.B.L., E.D., A.M.C., R.Z., M.E.C., Z.C., L.D.L., Y.H.C., R.S.S., D.P.D., A.B.G. and J.E.D. are employees of Novartis. I.S. was an employee of Novartis and is currently an employee of Yarrow Biotechnology. B.D. was an employee of Novartis and is currently an employee of Tango Therapeutics. A.A. and J.L.H. are employees of AstraZeneca. K.T., M.A. and I.K. are employees of Astellas Pharma. A.R.S. and J.L.R. are employees of the Regeneron Genetics Center. The other authors declare no competing interests.
